Funding Rounds
Causaly

Causaly Series B (2023, $60M)

Causaly

Biomedical research discovery tool.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $60.00M

Investors